Laura Sepp-Lorenzino
CIK 1777421 · EVP, Chief Scientific Officer · last filed 2026-06-02
Laura Sepp-Lorenzino is an EVP, Chief Scientific Officer who has filed 23 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for TSHA, was dated Jun 2, 2026. Across all open-market trades the lifetime net is −$19.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.66M
2
23
-$19.26M
Holdings By Company
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | TSHA | Grant (A) | +21,335 | $0 | EDGAR |
| 2025-06-04 | TSHA | Grant (A) | +56,623 | $0 | EDGAR |
| 2025-01-07 | NTLA | Sell (S) | −8,966 | -$109.2K | EDGAR |
| 2025-01-03 | NTLA | Exer (M) | +3,500 | $0 | EDGAR |
| 2024-05-31 | TSHA | Grant (A) | +49,220 | $0 | EDGAR |
| 2024-03-05 | NTLA | Grant (A) | +37,966 | $0 | EDGAR |
| 2024-01-10 | NTLA | Sell (S) | −2,275 | -$65.7K | EDGAR |
| 2024-01-05 | NTLA | Sell (S) | −5,532 | -$163.0K | EDGAR |
| 2024-01-03 | NTLA | Exer (M) | +3,500 | $0 | EDGAR |
| 2023-06-26 | TSHA | Grant (A) | — | $0 | EDGAR |